Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer (KHAD)
This study has been completed.
Sponsor:
Beth Israel Deaconess Medical Center
Collaborators:
Massachusetts General Hospital
Dana-Farber Cancer Institute
Sunnybrook Health Sciences Centre
Oregon Health and Science University
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center
Information provided by (Responsible Party):
Steven Balk, MD, Dana-Farber Cancer Institute
ClinicalTrials.gov Identifier:
NCT00673127
First received: May 5, 2008
Last updated: December 27, 2012
Last verified: December 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2012 |
| Primary Completion Date: | February 2012 (Final data collection date for primary outcome measure) |